Literature DB >> 19641664

Fibrinolytic effects of Ginkgo biloba extract.

Gholam Ali Naderi1, Seddigheh Asgary, Abbas Jafarian, Nazila Askari, Alireza Behagh, Roya Hasani Aghdam.   

Abstract

A multitude of factors are involved in regulating the blood coagulation homeostatic processes in the body, which may ultimately lead to thromboemboli and thrombosis. The resolution of blood clots after healing is as important as clot formation at the site of a vascular lesion. This is accomplished by fibrinolytic drugs such as streptokinase (SK) and urokinase.It must be noted that administration of SK may be accompanied by the lysis of blood clots in unwanted sites, and complications such as general lytic conditions, severe hemorrhaging, reduced serum fibrinogen and allergies can occur. Anti-SK antibodies neutralize the effects of SK. Studies on natural compounds and medicinal herbs with fewer side effects have been ongoing. In the present study, the fibrinolytic effect of Ginkgo biloba, an herb grown in Iran, was investigated.A polyphenolic method was used to obtain Ginkgo extract from its leaves. The fibrinolytic effects of SK (positive control) were compared with those of Ginkgo extract using a fluorometry method.In producing a labelled clot, fibrinogen was labelled with the fluorescent agent fluorescein isothiocyanate and precipitated in the presence of Ca(2+). SK (100 U/mL to 1000 U/mL) and Ginkgo extract were added to labelled fibrin in a plasma environment at dilutions of 1, 1:10, 1:100 and 1:1000 (volume/volume). The fluorescence of the solution was measured between 15 min and 60 min later.A linear relationship was observed between the fluorescence measured and SK concentrations ranging from 300 U/mL to 700 U/mL. Ginkgo extract displayed a remarkable effect in resolving the clot. As Ginkgo extract remained in the environment, fluorescence increased notably, showing a time-dependent relationship.Overall, the results indicate that the effects of Ginkgo extract on the fibrinolytic system are similar to those of SK; hence, this herbal extract can be used as a complement to or a substitute for SK. Additionally, it is proposed that the effects of the active ingredients of Ginkgo extract should be studied in animals. Further studies are warranted for evaluating the possible side effects and toxicity of Ginkgo extract in human subjects.

Entities:  

Keywords:  Fibrinolytic; Ginkgo; Streptokinase

Year:  2005        PMID: 19641664      PMCID: PMC2716226     

Source DB:  PubMed          Journal:  Exp Clin Cardiol        ISSN: 1205-6626


  8 in total

1.  No alteration in platelet function or coagulation induced by EGb761 in a controlled study.

Authors:  C Bal Dit Sollier; H Caplain; L Drouet
Journal:  Clin Lab Haematol       Date:  2003-08

2.  Influence of a 7-day treatment with Ginkgo biloba special extract EGb 761 on bleeding time and coagulation: a randomized, placebo-controlled, double-blind study in healthy volunteers.

Authors:  Stephan Köhler; Petra Funk; Meinhard Kieser
Journal:  Blood Coagul Fibrinolysis       Date:  2004-06       Impact factor: 1.276

3.  Superficial accumulation of plasminogen during plasma clot lysis.

Authors:  D V Sakharov; D C Rijken
Journal:  Circulation       Date:  1995-10-01       Impact factor: 29.690

4.  The effect of flow on lysis of plasma clots in a plasma environment.

Authors:  D V Sakharov; D C Rijken
Journal:  Thromb Haemost       Date:  2000-03       Impact factor: 5.249

5.  Antibodies to prothrombin crossreact with plasminogen in patients developing myocardial infarction.

Authors:  M Puurunen; M Mänttäri; V Manninen; T Palosuo; O Vaarala
Journal:  Br J Haematol       Date:  1998-02       Impact factor: 6.998

6.  Antihaemostatic and antithrombotic effect of some antiplatelet agents isolated from Chinese herbs.

Authors:  C M Teng; F N Ko; J P Wang; C N Lin; T S Wu; C C Chen; T F Huang
Journal:  J Pharm Pharmacol       Date:  1991-09       Impact factor: 3.765

7.  Rearrangements of the fibrin network and spatial distribution of fibrinolytic components during plasma clot lysis. Study with confocal microscopy.

Authors:  D V Sakharov; J F Nagelkerke; D C Rijken
Journal:  J Biol Chem       Date:  1996-01-26       Impact factor: 5.157

8.  Streptokinase resistance: when might streptokinase administration be ineffective?

Authors:  M B Buchalter; G Suntharalingam; I Jennings; C Hart; R J Luddington; R Chakraverty; S K Jacobson; P L Weissberg; T P Baglin
Journal:  Br Heart J       Date:  1992-11
  8 in total
  3 in total

1.  In vitro thrombolytic activity of Dhamasa (Fagonia arabica Linn.), Kushta (Saussurea lappa Decne.), and Guduchi (Tinospora cordifolia Thunb.).

Authors:  Shweta Chaudhary; Pawan Kumar Godatwar; Reetu Sharma
Journal:  Ayu       Date:  2015 Oct-Dec

2.  Effects of organic extracts of six Bangladeshi plants on in vitro thrombolysis and cytotoxicity.

Authors:  M Atiar Rahman; Rabeya Sultana; Talha Bin Emran; M Saiful Islam; M Ashiqur Rahman; Joti Sankhar Chakma; Harun-ur Rashid; Chowdhury Mohammad Monirul Hasan
Journal:  BMC Complement Altern Med       Date:  2013-01-30       Impact factor: 3.659

Review 3.  Ginkgo Biloba Extract in Ophthalmic and Systemic Disease, With a Focus on Normal-Tension Glaucoma.

Authors:  Margarita Labkovich; Erica B Jacobs; Siddharth Bhargava; Louis R Pasquale; Robert Ritch
Journal:  Asia Pac J Ophthalmol (Phila)       Date:  2020 May-Jun
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.